International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8007278
Original Article
Study on Thyroid Profile in Patients with Chronic Kidney Disease in Tertiary Care Centre
 ,
 ,
 ,
 ,
Published
June 5, 2023
Abstract
Introduction: Thyroid dysfunction is a prevalent endocrine disorder in patients with chronic kidney disease (CKD). This study aimed to evaluate the status of thyroid hormone profile in different stages of CKD and explore the associations between thyroid dysfunction and clinical variables. Methods: A cross-sectional study was conducted among 100 CKD patients admitted at Tertiary care centre. Demographic and clinical data, along with thyroid hormone levels, were collected and analyzed. Statistical analysis was performed using descriptive statistics, chi-square test, and odds ratios. Results: The prevalence of thyroid dysfunction among CKD patients was 39%, with subclinical hypothyroidism being the most common type (22%), followed by overt hypothyroidism (10%). No significant differences were observed in age or sex distribution among different CKD stages (p > 0.05). There were no significant associations between thyroid dysfunction and the presence of diabetes mellitus, hypertension, or cardiovascular disease in CKD patients (p > 0.05). The levels of urea, creatinine, and estimated glomerular filtration rate varied significantly across CKD stages (p < 0.01). However, thyroid hormone levels (Free T3, Free T4) did not show significant differences among stages, except for thyroid-stimulating hormone (TSH) (p < 0.01). Conclusion: This study highlights the high prevalence of thyroid dysfunction in CKD patients, predominantly characterized by subclinical hypothyroidism. Age, sex, diabetes mellitus, hypertension, and cardiovascular disease showed no significant associations with thyroid dysfunction. The levels of urea, creatinine, and eGFR varied significantly across different CKD stages, indicating the impact of kidney function on thyroid hormone regulation. Further research is needed to better understand the complex relationships between thyroid dysfunction, comorbidities, and CKD.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1025 Views
109 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved